Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.
Clinical fit
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Exact purpose
Research pending
Needs research Exact FDA submission Checked 2026-08-13
The prior extraction failed the specificity or text-quality gate. Re-extract the exact indication from ACR AI Central or current FDA labeling.
Intended users
Research pending
Needs research Exact FDA submission Checked 2026-08-31
Identify the intended clinical user and the human action expected after the output.
Care setting and population
Research pending
Needs research Exact FDA submission Checked 2026-08-31
Confirm the intended care setting, patient population, and service line.
Workflow role
Research pending
Needs research Exact FDA submission Checked 2026-08-31
Confirm whether the tool is concurrent reading, triage, post-processing, planning, acquisition support, or another workflow role.
Required input
Research pending
Needs research Exact FDA submission Checked 2026-08-31
Confirm input modality, image types, series requirements, acquisition protocol, and minimum data quality.
Output and human action
Research pending
Needs research Exact FDA submission Checked 2026-08-31
Confirm the exact output, destination, display location, and human action. The generic catalog description is not sufficient.
Limitations
Research pending
Needs research Exact FDA submission Checked 2026-08-31
Confirm contraindications, unsupported populations, scanners, protocols, and known failure modes.
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
FDA submission
K183046
FDA source Exact FDA submission Checked 2026-08-31
Use these fields to structure a vendor demo, security review, and implementation estimate.
Integration
Standards-based DICOM/PACS integration was identified in the FDA submission materials; compatibility with a specific PACS, RIS, EHR, or orchestrator requires confirmation.
Public source Exact FDA submission Checked 2026-08-13
Normalized from the prior exact-submission review. Confirm interface versions and local compatibility during technical evaluation.
Needs research Exact FDA submission Checked 2026-08-31
Attach an exact-product deployment and data-flow source.
Security and privacy
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13
FDA authorization does not establish the current commercial security posture. Request data-flow diagrams, hosting and retention details, access controls, audit logging, attestations, and incident-response documentation.
Training and support
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13
Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.
Monitoring and change control
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13
Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.
Evidence
Performance evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.
Evidence summary
Research pending
Needs research Exact FDA submission Checked 2026-08-31
No exact-version evidence summary has been curated yet.
Reported sensitivity
Research pending
Needs research Exact FDA submission Checked 2026-08-31
This field has not been curated yet.
Reported specificity
Research pending
Needs research Exact FDA submission Checked 2026-08-31
This field has not been curated yet.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Economics and lifecycle
Budget and ongoing governance
These are common procurement questions; unknown values remain visible until a source supports them.
Pricing and total cost
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13
FDA submission materials do not establish current commercial pricing. Request the pricing unit, term, minimum commitment, implementation fees, and included support from the vendor.
Reimbursement and coding
Research pending
Needs research Exact FDA submission Checked 2026-08-31
Determine whether any product-specific CPT/HCPCS pathway exists and separate it from billing for the underlying imaging service.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-02
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Buyer worksheet
Open questions to take to the vendor
Verify exact intended use: The prior extraction failed the specificity or text-quality gate. Re-extract the exact indication from ACR AI Central or current FDA labeling.
Verify anatomy and target condition: The FDA list or current public sources do not specify anatomy for this exact submission.
Verify intended users: Identify the intended clinical user and the human action expected after the output.
Verify care setting and population: Confirm the intended care setting, patient population, and service line.
Verify workflow role: Confirm whether the tool is concurrent reading, triage, post-processing, planning, acquisition support, or another workflow role.
Verify required inputs and acquisition protocol: Confirm input modality, image types, series requirements, acquisition protocol, and minimum data quality.
Verify output and human action: Confirm the exact output, destination, display location, and human action. The generic catalog description is not sufficient.
Verify limitations: Confirm contraindications, unsupported populations, scanners, protocols, and known failure modes.
Verify deployment and data flow: Attach an exact-product deployment and data-flow source.
Verify security and privacy controls: FDA authorization does not establish the current commercial security posture. Request data-flow diagrams, hosting and retention details, access controls, audit logging, attestations, and incident-response documentation.
Verify training: Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.
Verify pricing and total cost: FDA submission materials do not establish current commercial pricing. Request the pricing unit, term, minimum commitment, implementation fees, and included support from the vendor.
Verify reimbursement and coding relevance: Determine whether any product-specific CPT/HCPCS pathway exists and separate it from billing for the underlying imaging service.
Verify exact-version clinical evidence: No exact-version evidence summary has been curated yet.
Verify local validation and lifecycle monitoring: Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.
Verify recalls and postmarket safety signals: No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-02Last searched
6Fields reviewed
5Source classes checked
0Unreviewed PubMed leads
0Unreviewed trial leads
0Unreviewed FDA recall leads
Recovered from the prior exact-submission extraction and normalized under the current provenance rules. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads remain unpublished until a human confirms the exact product and tested version.
Source classes: fda ai list, fda decision summary, pubmed, clinical trials, openfda device recall
FDA product code JAK identifies this device class as System, X-Ray, Tomography, Computed. Consult the linked FDA record for the exact authorized indications for use.
FDA product code JAK identifies this device class as System, X-Ray, Tomography, Computed. Consult the linked FDA record for the exact authorized indications for use.
FDA product code JAK identifies this device class as System, X-Ray, Tomography, Computed. Consult the linked FDA record for the exact authorized indications for use.
FDA product code JAK identifies this device class as System, X-Ray, Tomography, Computed. Consult the linked FDA record for the exact authorized indications for use.